NCT06061185 Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke
| NCT ID | NCT06061185 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xiaolin Chen, MD |
| Condition | Acute Hemorrhagic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2032-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2020-01-01 with a primary completion date of 2032-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Acute hemorrhagic stroke is a series of neurosurgical diseases characterized by bleeding with high morbidity and mortality. It accounts for about 20% of all strokes worldwide and mainly includes subtypes such as intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Multimodal computed tomography including non-contrast computed tomography, computed tomography angiography and computed tomography perfusion, is of great important in understanding pathophysiological changes, evaluating prognosis and guiding interventions in these diseases.
Eligibility Criteria
Inclusion Criteria: 1. age ≥ 18, ≤ 85 years; 2. presence with hemorrhagic stroke Exclusion Criteria: 1. with a history of previous history of ischemic/hemorrhagic stroke; 2. admission to the emergency department more than a week after symptom onset; 3. serious medical history or existing comorbidities; 4. physical disability due to previous diseases; 5. prior treatment such as external ventricular drainage, digital subtraction angiography and lumbar puncture in other institution; 6. poor original image quality; 7. incomplete follow-up.
Contact & Investigator
Tu Li, M.D.
STUDY CHAIR
Beijing Tiantan Hospital
Frequently Asked Questions
Who can join the NCT06061185 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Acute Hemorrhagic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06061185 currently recruiting?
Yes, NCT06061185 is actively recruiting participants. Contact the research team at chenxiaolin@bjtth.org for enrollment information.
Where is the NCT06061185 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06061185 clinical trial?
NCT06061185 is sponsored by Xiaolin Chen, MD. The principal investigator is Tu Li, M.D. at Beijing Tiantan Hospital. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.